carbonthatcarbonthat
← Every company

Agios Pharmaceuticals Inc Insider Trading

Every director, officer and 10% holder of Agios Pharmaceuticals Inc has to report each trade in its stock within two business days of making it. This is those filings.

AGIO on carbonthat →
Insiders filing
2
6 reported lines
Open-market buys
0
Open-market sales
2
$1.1M
Net
$1.1M
sold more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Sarah GheuensChief Medical Officer2026-08-0430K shat $30.48
Sale10b5-1 plan
$914.4K
Sarah GheuensChief Medical Officer2026-07-014K shat $37.56
Sale10b5-1 plan
$150.5K

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on AGIO

Company overviewEverything on AGIO in one place, with the price.SEC filingsWhat AGIO's 8-Ks say happened: results, departures, auditor changes.Who owns itEvery manager reporting a position in AGIO.Funds holding itWhich funds and ETFs hold AGIO, and how big a bet.LobbyingWhat AGIO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AGIO's account, and who they worked for.Federal contractsWhat federal agencies pay AGIO.PatentsWhat AGIO is filing at the patent office.

Follow Agios Pharmaceuticals Inc (AGIO) by email

New trades in Agios Pharmaceuticals Inc (AGIO) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.